Author:
Passamonti Francesco,Harrison Claire N.,Mesa Ruben A.,Kiladjian Jean-Jacques,Vannucchi Alessandro M.,Verstovsek Srdan
Reference99 articles.
1. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology;Aaronson;J. Natl. Cancer Inst.,1993
2. Thalidomide versus placebo in myeloid metaplasia with myelofibrosis: a prospective, randomized, double-blind, multicenter study;Abgrall;Haematologica,2006
3. Primary analysis of JUMP, a phase 3b, expanded-access study evaluating the safety and efficacy of ruxolitinib in patients with myelofibrosis, including those with low platelet counts;Al-Ali;Br. J. Haematol.,2020
4. Androgens and anemia: current trends and future prospects;Al-Sharefi;Front. Endocrinol.,2019
5. Current and future therapies for myelofibrosis;Asher;Blood Rev.,2020
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献